Universal access to antiretroviral therapy may be the best approach to 'Do no harm' in developing countries: The Brazilian experience [6]

AIDS

Volumn 17, Issue 5, 2003, Pages 786-787

  Remien, Robert H ^a   Bastos, Francisco Inàcio ^b   Berkman, Alan ^a   Terto Jr , Veriano ^c   Raxach, Juan Carlos ^c   Parker, Richard G ^a,c,d  

^a NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

^c Brazilian Interdisciplinary AIDS Association (ABIA)   (Brazil)

^d NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

BRAZIL; DEVELOPING COUNTRY; FEMALE; HEALTH CARE ACCESS; HEALTH CARE SYSTEM; HEALTH PROGRAM; HOSPITALIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INDUSTRIALIZATION; LETTER; MALE; MORTALITY; PATIENT COMPLIANCE; PATIENT COUNSELING; PRIORITY JOURNAL;

ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BRAZIL; DEVELOPING COUNTRIES; HIV INFECTIONS; HUMANS; PATIENT COMPLIANCE;

EID: 0242499897     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200303280-00030     Document Type: Letter

References (6)

1. Popp D, Fisher JD. First, do no harm: a call for emphasizing adherence and HIV prevention interventions in active antiretroviral therapy programs in the developing world [Letter]. AIDS 2002; 16:676-678.
2. Bastos FI, Kerrigan D, Malta M, Cameiro-da-Cunha C, Strathdee SA. Treatment for HIV/AIDS in Brazil: strengths, challenges, and opportunities for operations research. AIDScience (Science knowledge environment) 2001; I(15): 27 November 2001. Available at www.aidscience.com
3. Merson MÒ The international agenda. NIMH - HIV prevention in treatment settings: US and international priorities. Washington, DC; 3 August 2001.
4. Bastos F, Hacker M, Terto V, Raxach JC, Bessa M, Parker RG, et al. Aderência á terapia anti-retroviral de alta potência no Rio de Janeiro, Brasil: revisão de alguns aspectos conceituais de principais achados empíricos do Projeto ABIA/Columbia University. Rio de Janeiro: ABIA; 2002.
5. Chesney M., Ickovics J. Adherence to combination therapy in AIDS clinical trials. Presented at the Annual Meeting of the AIDS Clinical Trials Group (ACTG) to the Recruitment, Adherence and Retention Committee of the ACTG. July 1997, Washington, DC.
6. Brigido LF, Rodrigues R, Casseb J, Oliveira D, Rossetti M, Menezes P, et al. Impact of adherence to antiretroviral therapy in HIV-1-infected patients at a university public service in Brazil. AIDS Patient Care STDS 2001; 15:587-593.